Related Experiment Video
Updated: Apr 12, 2026

07:00
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
17.7K
Tumour-derived miRNAs and bone metastasis.
Martine Croset1, Casina Kan1, Philippe Clézardin1
1INSERM, UMR 1033 , Lyon, France ; Faculté Médecine RTH Laennec, University of Lyon , Villeurbanne, France.
Bonekey Reports
|May 20, 2015
Summary
MicroRNAs (miRNAs) regulate key steps in bone metastasis formation for cancers like breast, prostate, and lung. These miRNAs show potential as biomarkers and therapeutic targets for skeletal complications.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Skeletal metastases are common in epithelial cancers, particularly breast, prostate, and lung carcinomas.
- Cancer cells metastasize via epithelial-mesenchymal transition, migrating to distant sites like bone.
- Bone metastasis involves circulating tumor cell recruitment, adaptation to the bone microenvironment, and interaction with bone cells.
Purpose of the Study:
- To explore the role of microRNAs (miRNAs) in the development of bone metastasis.
- To investigate miRNAs as potential biomarkers for bone metastasis.
- To assess the therapeutic potential of targeting miRNAs in bone metastasis.
Main Methods:
- Review of molecular pathways regulating bone metastasis.
- Analysis of gene expression control by miRNAs in cancer cells and bone microenvironment.
- Identification of miRNA signatures in osteotropic cancer cells.
Main Results:
- miRNAs act as master regulators of gene expression in bone metastasis.
- miRNAs control cancer cell escape, dissemination, invasion, and outgrowth in bone.
- Specific miRNA signatures are found in osteotropic cancer cells.
Conclusions:
- miRNAs play a crucial role in multiple stages of bone metastasis formation.
- miRNAs are promising biomarkers for detecting bone metastasis.
- Targeting miRNAs offers a potential therapeutic strategy for bone metastasis.
Related Concept Videos
MicroRNAs
24.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
MicroRNAs
4.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
Metastasis
6.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment
3.2K
3.2K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K

